Two PerkinElmer Tests Added to UK’s Updated NICE Diagnostic Guidance for Suspected Preterm Pre-Eclampsia

WALTHAM, Mass.–(BUSINESS WIRE)–PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that a placental growth factor (PlGF) measurement using its DELFIA® Xpress PlGF 1-2-3TM kit (CE-IVD) and a soluble fms-like tyrosine kinase 1 (sFlt-1)/PlGF ratio using its DELFIA® Xpress sFlt-1 kit (CE-IVD), have been included in an updated diagnostic guidance issued by the United Kingdom’s National... Read more

MKS Instruments Declares Quarterly Cash Dividend

ANDOVER, Mass., July 26, 2022 (GLOBE NEWSWIRE) — MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of technologies that enable advanced processes and improve productivity, today announced that its Board of Directors has authorized a quarterly cash dividend of $0.22 per share, payable on Read more

Wipro GE Healthcare: New factory launched under PLI to boost local manufacturing

With an investment of over INR 100 crores, this greenfield facility is one of 15 medical device manufacturers approved under the government’s PLI Scheme towards Atmanirbhar Bharat Wipro GE Healthcare, a leading global medical technology and digital solutions innovator, today announced the launch of its new manufacturing facility in Bengaluru, India, under the Indian government’s... Read more

GE Healthcare unveils latest ultra-premium ultrasound in Women’s Health portfolio

Voluson Expert 22 represents a major step forward in ultrasound innovation from a market leader in Women’s Health Ultrasound Next-generation architecture behind Voluson Expert 22 includes Voluson graphic-based beam former technology; AI powered tools; and customizable touch panel, color and lighting options. Chicago (July 21, 2022) –  GE Healthcare today unveiled its most advanced ultrasound... Read more

PerkinElmer Elects Dr. Michelle McMurry-Heath to its Board of Directors

WALTHAM, Mass.–(BUSINESS WIRE)–Jul. 22, 2022– PerkinElmer, Inc. (NYSE:PKI), a global leader committed to innovating for a healthier world, today announced that Dr. Michelle McMurry-Heath has been elected to its board of directors, effective July 22, 2022. “I am pleased to welcome Michelle to PerkinElmer’s board and excited to see the Company benefit from both her... Read more

Nanalysis Scientific Corp. Announces Management Transitions

CALGARY, AB, July 21, 2022 /CNW/ – Nanalysis Scientific Corp. (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1) (“Nanalysis” or the “Company”) announces that the current CFO, Luke Caplette, is stepping down as CFO, but will remain with the Company as a part-time consultant to assist the transition to a new CFO. The Company is pleased that its Corporate Controller, Randall McRae, has been... Read more